U.S. Central Venous Catheter Market is expected to exhibit a CAGR of 6.2% With Major Players AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated

Central venous catheters play a crucial role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

The U.S. central venous catheter market was evaluated at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018-2026).

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2610

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney. In 2012, the World Health Organization (WHO), cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. It further stated that the number of new cases is likely to increase by around 70% by the year 2030.

Increasing collaboration strategies adopted by market players to bolster market development

The U.S. central venous catheter market is expected to witness significant growth due to the rising adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2610

Major Players Are Operating In This Market Are: AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation

Highlights of the U.S. Central Venous Catheter report:

1. A complete backdrop analysis, which includes an assessment of the U.S. Central Venous Catheter Market
2. An objective assessment of the trajectory of the market
3. Market segmentation up to the second or third level
4. Reporting and evaluation of recent industry developments
5. Important changes in market dynamics
6. Emerging niche segments and regional markets
7. Historical, current, and projected size of the market from the standpoint of both value and volume
8. Market shares and strategies of key players
9. Recommendations to companies for strengthening their foothold in the market

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.